|
- 2018
Study protocol: phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasisDOI: 10.1515/pp-2018-0118 Keywords: dose escalation, oxaliplatin, peritoneal carcinomatosis, phase I, PIPAC, study protocol Abstract: Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) is a novel laparoscopic intraperitoneal chemotherapy technique, with advantages such as homogeneous distribution of aerosol and deeper tissue penetration. Thus far, PIPAC oxaliplatin has been administered at an arbitrary dose of 92?mg/m2
|